Lingjie Wu
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery 6
- Biomedical Engineering top 5%
- Nanoplatforms for cancer theranostics 11
- Materials Chemistry top 10%
- Advanced Nanomaterials in Catalysis 3
-
- Advanced biosensing and bioanalysis techniques 5
-
- Antibiotics Pharmacokinetics and Efficacy 4
-
- COVID-19 Clinical Research Studies 3
-
- Liver Disease Diagnosis and Treatment 3
-
- Renal Transplantation Outcomes and Treatments 2
In The Last Decade
Lingjie Wu
28 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 93
- Biomaterials 343
- Biomedical Engineering 903
- Materials Chemistry 509
- Electronic, Optical and Magnetic Materials 131
- Pulmonary and Respiratory Medicine 202
Countries citing papers authored by Lingjie Wu
This map shows the geographic impact of Lingjie Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingjie Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingjie Wu more than expected).
Fields of papers citing papers by Lingjie Wu
This network shows the impact of papers produced by Lingjie Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingjie Wu. The network helps show where Lingjie Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lingjie Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 0 | |
| 6 | 2025 | 0 | |
| 7 | 2024 | 1 | |
| 8 | 2022 | 2 | |
| 9 | 2021 | 1 | |
| 10 | 2020 | 13 | |
| 11 | 2020 | 0 | |
| 12 | 2019 | 16 | |
| 13 | 2017 | 4 | |
| 14 | 2016 | 51 | |
| 15 | 2016 | 77 | |
| 16 | 2016 | 24 | |
| 17 | 2014 | 61 | |
| 18 | 2013 | 47 | |
| 19 | 2012 | 38 | |
| 20 | Chemical and biological differentiation of three human breast cancer cell types using time-of-flight secondary ion mass spectrometry (TOF-SIMS) | 2006 | 2 |
About Lingjie Wu
Lingjie Wu is a scholar working on Transplantation, Biomaterials and Hepatology, having authored 35 papers that have together received 1.3k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (11 papers), Nanoparticle-Based Drug Delivery (6 papers), Advanced biosensing and bioanalysis techniques (5 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), COVID-19 Clinical Research Studies (3 papers), Advanced Nanomaterials in Catalysis (3 papers), Liver Disease Diagnosis and Treatment (3 papers) and Renal Transplantation Outcomes and Treatments (2 papers). The work is most often cited by research in Biomaterials (343 citations), Biomedical Engineering (903 citations) and Materials Chemistry (509 citations). Lingjie Wu has collaborated with scholars based in China, Egypt and Rwanda. Frequent co-authors include Xiaolong Liu, Ming Wu, Da Zhang, Jingfeng Liu, Yongyi Zeng, Huanghao Yang, Aixian Zheng, Qingtang Wang, Juan Li and Xiao Han. Their work appears in journals such as Analytical Chemistry, ACS Applied Materials & Interfaces and Nanoscale.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.